BRILINTA 90 mg/1

BRILINTA 90 mg is an oral tablet containing ticagrelor, used to prevent blood clots in certain heart conditions. This medication is commonly prescribed for patients with acute coronary syndrome or those undergoing coronary stent procedures.

BRILINTA 90 mg is primarily used to reduce the risk of blood clots in individuals with acute coronary syndrome (ACS) or those who have undergone a coronary stent procedure. It works by inhibiting platelet aggregation, which helps maintain blood flow and prevents clot formation. This medication is often used in conjunction with low-dose aspirin for enhanced effectiveness.

Common effects of BRILINTA 90 mg may include bleeding, bruising, and shortness of breath. Some users might experience dizziness or fatigue. It is important to monitor for any signs of unusual bleeding, as this can be a serious side effect.

BRILINTA 90 mg should be handled with care, especially by individuals with a history of bleeding disorders or those taking other blood-thinning medications. It is crucial to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Always store the tablets in a cool, dry place away from direct sunlight.

BRILINTA 90 mg may interact with other medications, including blood thinners, NSAIDs, and certain antidepressants. Alcohol consumption should be limited, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.